Dec 1st, 2022 - People with acute respiratory illness during the pandemic suffered similar levels of poor well-being in the months afterward whether they tested positive for SARS-CoV-2 or not, a registry study showed. In a cohort of people who all had initial symptoms suggestive of COVID-19, those who had moderate to severe scores at 3 months on the pain, mood, and other quality-of-life measures on the Patient...

Dec 1st, 2022 - Experts discussed the obstacles to caring for young people with mental health problems as they transition from high school to college during a hearing of the Senate Health, Education, Labor, and Pensions (HELP) Subcommittee on Children and Families on Wednesday. Witnesses pressed Congress to invest more in the treatments for first-episode psychosis and to increase education on more serious and ...

Dec 1st, 2022 - Unmet socioeconomic needs had a significant association with overactive bladder (OAB), adding to evidence of a complex interaction between social determinants of health and OAB, researchers said. Stressors such as housing and food insecurity and concerns about personal health as much as tripled the odds of reported OAB symptoms. The stressors remained significant predictors for OAB after adjust...

Dec 1st, 2022 - Japan's mass screening and counseling intervention resulted in only modest population-wide improvements in obesity and cardiovascular disease (CVD) risk factors, a study showed. Among over 3.4 million men and 2.3 million women, those who met the threshold for high waist circumference with high blood pressure, impaired glucose tolerance, or dyslipidemia and received lifestyle guidance and counse...

Dec 1st, 2022 - Second-line treatment for diffuse large B-cell lymphoma (DLBCL) got a big boost in 2022 with new indications for a pair of chimeric antigen receptor (CAR) T-cell therapies, while an antibody-drug conjugate moved one step closer to shaking up treatment in the first-line setting. CAR-T Products Move to Second-Line In April, axicabtagene ciloleucel (axi-cel; Yescarta) became the first CAR T-cell t...

Dec 1st, 2022 - Wearing glasses in public for 2 weeks did not protect against SARS-CoV-2 infection, a Norwegian pragmatic randomized trial showed. Among more than 3,700 participants, 3.7% of those randomized to wear sunglasses or other types of glasses in the community reported a positive COVID test to the Norwegian Surveillance System for Communicable Diseases compared with 3.5% of those in the control group ...

Dec 1st, 2022 - This transcript has been edited for clarity. Anne Cross, MD: Hello. I'm Anne Cross. Welcome to Medscape's InDiscussion series on multiple sclerosis. And today we're going to take on the somewhat controversial topic of the use of cannabis and cannabinoids in the treatment of symptoms in patients with multiple sclerosis. We have an expert to speak to us today about this, Dr Jacquelyn Bainbridge, ...

Dec 1st, 2022 - In 2019, a New York Times opinion piece titled, “The Big IVF Add-On Racket – This is no way to treat patients desperate for a baby”[1] alleged exploitation of infertility patients based on a Fertility and Sterility article, “Do à la carte menus serve infertility patients? The ethics and regulation of in vitro fertility add-ons.”[2] The desperation of infertility patients combined with their fin...

Dec 1st, 2022 - The debate over whether or not to test for DPYD gene variants before administering fluoropyrimidine (FP) chemotherapy has erupted again among experts in the United States, where such testing is not recommended at present, unlike in Europe. Testing for DPYD variants and subsequent dose adjustment should be offered to US patients who are due to receive fluoropyrimidine chemotherapy, says Daniel L...

Nov 30th, 2022 - A simulated driving program reduced inattention and risk of crashing among teens with attention deficit-hyperactivity disorder (ADHD) compared with conventional driver's training, according to a small study that used a program combining computer-based and driving simulator training. During 15-minute simulated drives, teens in the training group had a mean of 16.5 long glances (>2 seconds) from ...

Nov 30th, 2022 - When it comes to developing long COVID, certain people may have a higher risk than others, researchers reported. According to an online survey of people who tested positive in 2020, 52.1% said they experienced post-COVID syndrome symptoms, said Vassilios Vassiliou, PhD, of the University of East Anglia in Norwich, England, and colleagues. One of the top predictors of exactly who might develop t...

Aerosolized glucocorticoid treatment was independently associated with bacterial isolation in these patients.

Nov 30th, 2022 - Despite use of advanced hemorrhage control interventions, more than one in three patients with hemodynamically unstable pelvic fractures died, a retrospective cohort study showed. Among nearly 1,400 patients who received early transfusions and at least one invasive pelvic hemorrhage control intervention, the 24-hour mortality rate was 15.5%, the emergency department mortality rate was 0.7%, and...

Nov 30th, 2022 - Note that some links may require subscriptions. All four monks at a Buddhist temple in central Thailand were defrocked after testing positive for methamphetamine use. (CBS News) New York City will begin involuntarily hospitalizing its homeless mentally ill residents, Mayor Eric Adams (D) said. (New York Times) A Minnesota woman lost part of her peripheral vision and inadvertently put her family...

Nov 30th, 2022 - BEIJING (Reuters) -China will speed up COVID-19 vaccinations for elderly people, health officials said on Tuesday, aiming to overcome a key stumbling block in efforts to ease unpopular "zero-COVID" curbs. The move is seen as a crucial element in a strategy to unwind nearly three years of strict curbs that have eroded economic growth, disrupted the lives of millions, and sparked unprecedented we...

Nov 30th, 2022 - Artificial intelligence could help improve diversity, equity, and inclusion in clinical trials and drug development by overcoming some traditional human bias in these areas, but we're not there yet, experts say. The technology could also assist doctors with data insights to make diagnosis and treatment more precise. It starts with quality. Artificial intelligence (AI) relies on large amounts of...

Nov 30th, 2022 - Despite recent efforts to improve the landscape of diversity, equity, and inclusion in medicine, advances in the field of dermatology have been unremarkable to date, results from two cross-sectional studies recently published in JAMA Dermatology suggest. Dr Matthew Mansh To evaluate diversity and career goals of graduating allopathic medical students pursuing careers in dermatology, correspondi...

Nov 30th, 2022 - Editor's note: Find the latest COVID-19 news and guidance in Medscape's Coronavirus Resource Center. Almost 9 out of 10 COVID-19 deaths are among people 65 and older -- the highest rate yet for elderly fatalities since the pandemic began, according to an analysis by The Washington Post. The Centers for Disease Control says more than 300 people die each day from COVID-19 – down from the 2,000 or...

Nov 30th, 2022 - Amazon is encouraging patients to "skip the waiting room" with the launch of Amazon Clinic, a virtual health care service that aims to offer treatment for nearly 2 dozen common health conditions. Taking a step beyond a typical telehealth visit, the service promises personalized treatment with no appointments, video calls, or live chat. Patients can answer questions about their symptoms and heal...

Nov 30th, 2022 - Using buprenorphine for opioid use disorder in pregnancy was linked with a lower risk of neonatal side effects than using methadone, but the risk of adverse maternal outcomes was similar between the two treatments, according to new research. Elizabeth A. Suarez, PhD, MPH, with Brigham and Women's Hospital in Boston, led the study published online in the New England Journal of Medicine. Opioid u...